Literature DB >> 7543923

Regulation of NK cells through the 80-kDa TNFR (CD120b).

A T Mason1, D W McVicar, C A Smith, H A Young, C F Ware, J R Ortaldo.   

Abstract

By using monoclonal antibody specific for tumor necrosis factor receptor80 (TNFR80) (CD120b) and TNFR60 (CD120a), we determined which receptor transduces the signals involved in activating natural killer (NK) cells. Purified CD56+CD3- large lymphocytes express TNFR80 but not TNFR60 and interleukin-2 (IL-2) up-regulates TNFR80 expression, consistent with NK cells being activated in vivo. Treatment of NK cells with anti-TNFR80 for 18 h enhanced the NK activity detected on K562 target cells mimicking the effect of TNF. In combination with IL-2, TNF enhanced the development of lymphokine-activated killing. However, only anti-TNFR80 abrogated IL-2 induction of lymphokine-activated killer cell activity. The activity of TNF or anti-TNFR80 was selective for NK cytotoxic function because they did not directly mimic IL-2 activation or induce significant proliferation, expression of cell surface activation antigens (CD25 or HLA-DR), or interferon-gamma secretion. These results indicate that TNFR80 is an important signal transducing receptor for the differentiation of NK cells induced by TNF and IL-2.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7543923     DOI: 10.1002/jlb.58.2.249

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  8 in total

1.  Virally infected and matured human dendritic cells activate natural killer cells via cooperative activity of plasma membrane-bound TNF and IL-15.

Authors:  Lazar Vujanovic; David E Szymkowski; Sean Alber; Simon C Watkins; Nikola L Vujanovic; Lisa H Butterfield
Journal:  Blood       Date:  2010-04-29       Impact factor: 22.113

2.  Essential role of the TNF-TNFR2 cognate interaction in mouse dendritic cell-natural killer cell crosstalk.

Authors:  Jun Xu; Ayan K Chakrabarti; Jennifer L Tan; Lisheng Ge; Andrea Gambotto; Nikola L Vujanovic
Journal:  Blood       Date:  2006-12-12       Impact factor: 22.113

3.  TNFα Augments Cytokine-Induced NK Cell IFNγ Production through TNFR2.

Authors:  Wagdi Almishri; Tania Santodomingo-Garzon; Tyson Le; Danuta Stack; Christopher H Mody; Mark G Swain
Journal:  J Innate Immun       Date:  2016-08-25       Impact factor: 7.349

4.  Sequential activation of NKT cells and NK cells provides effective innate immunotherapy of cancer.

Authors:  Mark J Smyth; Morgan E Wallace; Stephen L Nutt; Hideo Yagita; Dale I Godfrey; Yoshihiro Hayakawa
Journal:  J Exp Med       Date:  2005-06-20       Impact factor: 14.307

5.  Colocalization of endogenous TNF with a functional intracellular splice form of human TNF receptor type 2.

Authors:  Christoph Scherübl; Wulf Schneider-Brachert; Stephan Schütze; Thomas Hehlgans; Daniela N Männel
Journal:  J Inflamm (Lond)       Date:  2005-07-04       Impact factor: 4.981

6.  An explorative study on deep profiling of peripheral leukocytes to identify predictors for responsiveness to anti-tumour necrosis factor alpha therapies in ankylosing spondylitis: natural killer cells in focus.

Authors:  Ursula Schulte-Wrede; Till Sörensen; Joachim R Grün; Thomas Häupl; Heike Hirseland; Marta Steinbrich-Zöllner; Peihua Wu; Andreas Radbruch; Denis Poddubnyy; Joachim Sieper; Uta Syrbe; Andreas Grützkau
Journal:  Arthritis Res Ther       Date:  2018-08-29       Impact factor: 5.156

Review 7.  TNFR2: Role in Cancer Immunology and Immunotherapy.

Authors:  Yang Yang; Md Sahidul Islam; Yuanjia Hu; Xin Chen
Journal:  Immunotargets Ther       Date:  2021-04-21

8.  Pro- and Anti-Inflammatory Cytokines in the Context of NK Cell-Trophoblast Interactions.

Authors:  Valentina Mikhailova; Polina Grebenkina; Evgeniia Khokhlova; Alina Davydova; Zeina Salloum; Elizaveta Tyshchuk; Valeria Zagainova; Kseniia Markova; Igor Kogan; Sergey Selkov; Dmitry Sokolov
Journal:  Int J Mol Sci       Date:  2022-02-21       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.